Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644988-67657569	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;intestine: 13.4;lymphoid tissue: 21.6"	"Group enriched"	"Detected in some"	4	"B-cells: 3.6;dendritic cells: 3.7;T-cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;JURKAT: 47.3;MOLT-4: 64.6;REH: 105.6;RPMI-8226: 58.4;U-698: 107.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041402	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"	0.9	0.5	5.9	12.5	6.3	5.9	0.5	4.5	11.4	0.4	2.4	2.0	1.8	0.3	0.1	0.9	0.5	1.2	0.3	9.8	5.1	0.9	0.8	1.7	21.6	5.6	4.0	0.2	0.4	0.1	4.5	0.2	5.4	0.8	0.7	0.3	1.4	0.1	0.0	0.4	13.4	0.2	3.4	19.9	1.9	0.9	4.9	20.9	1.2	0.0	10.9	1.5	0.7	6.8	0.2	0.1	0.1	0.3	0.0	0.1	18.1	0.6	0.0	0.5	0.0	9.6	0.6	64.2	1.1	0.0	0.1	0.1	6.0	0.0	0.0	14.3	7.5	3.8	0.3	1.2	0.5	7.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	47.3	0.9	1.0	0.0	1.1	64.6	32.2	10.7	0.3	0.3	105.6	0.1	58.4	0.0	0.0	15.9	1.7	0.1	0.2	0.5	1.5	0.4	1.9	0.2	0.9	2.0	0.1	0.4	17.6	33.4	107.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.7	0.1	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.3	0.7	0.1	5.9	6.3	4.5	11.4	9.8	5.1	5.6	4.0	5.4	3.4	4.9	6.8	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"lymphoid tissue: 906.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 231.0;T-cells: 665.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	52	"gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4"	"Lineage enriched"	"Detected in all"	66	"T-cells: 1660.4"	"Group enriched"	"Detected in some"	4	"JURKAT: 621.5;MOLT-4: 1299.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	4.1	3.8	0.3	77.5	0.4	28.6	9.9	0.4	1.4	5.2	0.7	18.8	21.7	3.6	5.7	7.6	4.5	15.7	3.7	0.3	0.6	2.3	7.9	20.6	222.7	1.1	0.4	3.2	1.3	0.9	0.8	1.2	0.6	5.9	22.4	0.3	8.3	3.1	2.5	4.0	30.1	3.9	0.7	60.9	23.8	2.4	0.5	906.7	3.8	1.4	166.9	26.7	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	621.5	49.8	0.0	0.0	0.0	1299.8	237.2	1.2	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.2	0.8	0.0	0.5	0.0	1.5	1.1	0.0	0.9	1.1	0.4	0.0	0.1	0.0	10.1	5.3	4.6	1462.4	3.3	990.0	9.6	1206.1	1368.7	5.0	3.7	1091.4	1338.9	25.1	4.2	5.3	6.0	1660.4	1138.7	0.3	0.4	0.4	1.4	0.3	0.6	1.1	0.4	0.6	0.7	0.5	0.8	5.9	6.4	29.6	0.0	18.6	15.3	0.3	0.0	1.8	0.0	5.4	6.7	2.8	7.2	2.6	3.7	0.0	0.4	231.0	0.9	0.0	1.3	0.4	0.8	0.8	5.0	1.2	16.8	0.0	0.0	0.0	8.3	21.4	0.9	12.6	0.0	7.9	3.1	0.6	0.0	0.0	0.2	0.0	14.9	28.4	0.7	0.0	14.2	12.4	1.0	25.0	0.0	32.0	0.0	0.0	0.1	0.2	0.0	21.0	0.3	0.0	3.4	1.5	0.0	0.0	2.5	5.8	0.1	1.2	1.4	11.8	0.3	665.7	0.0	1.1	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.6;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5"	"Lineage enriched"	"Detected in many"	51	"T-cells: 51.4"	"Group enriched"	"Detected in some"	12	"JURKAT: 10.2;MOLT-4: 39.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	NA	NA	5270000	160000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.4	0.9	1.5	21.9	0.9	11.3	1.2	0.5	1.1	1.3	0.7	3.2	4.0	0.9	0.7	1.8	1.4	3.9	0.5	0.6	1.7	1.0	1.4	6.6	43.1	1.5	2.0	0.9	0.6	0.2	0.4	0.3	1.7	1.1	3.1	0.2	3.2	0.4	0.8	1.3	13.6	0.7	0.9	18.0	6.6	0.7	2.5	39.6	1.4	0.3	29.0	4.8	1.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.2	0.0	0.0	0.0	39.2	0.1	0.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.7	0.0	24.7	1.0	51.4	48.4	0.3	0.9	34.4	25.2	0.7	0.2	0.0	0.0	25.5	13.8	1.5	0.9	0.5	1.1	0.6	1.7	1.5	2.0	1.7	0.9	2.5	0.9	3.2	0.0	2.5	0.3	10.8	2.0	0.2	0.1	0.0	1.4	0.9	0.8	2.6	1.5	0.1	0.0	0.0	0.2	25.7	0.2	0.0	0.2	0.9	0.4	0.3	1.2	0.0	0.0	0.8	0.6	0.2	1.5	8.2	0.3	0.0	0.1	2.5	0.8	2.0	1.7	0.9	0.0	0.0	1.9	4.4	0.4	0.3	3.4	3.6	1.0	2.4	0.0	49.4	0.0	0.2	0.7	0.2	0.0	18.5	0.0	0.1	0.2	0.1	0.2	0.0	1.0	0.9	0.4	0.9	1.0	1.4	0.3	107.3	0.7	0.5	0.4
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 343.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	12	"gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7"	"Group enriched"	"Detected in all"	12	"NK-cells: 641.5;T-cells: 1682.7"	"Group enriched"	"Detected in some"	6	"JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	3.4	2.2	0.4	50.6	0.5	13.7	2.3	0.4	0.5	2.2	0.7	6.9	7.6	1.7	13.0	3.9	2.1	9.4	1.9	0.5	0.4	3.8	3.8	11.4	111.0	0.8	0.5	1.6	0.9	0.5	0.8	1.1	0.6	2.8	6.5	0.0	4.8	1.4	1.3	1.9	23.1	2.3	0.6	39.9	12.1	1.1	0.5	343.0	3.7	1.4	79.6	13.2	2.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.7	64.1	3.5	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	365.7	0.2	0.0	0.0	0.0	536.9	0.2	5.9	4.6	0.3	20.6	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.3	0.3	0.4	0.6	0.4	0.0	0.0	1.7	0.1	0.1	0.7	0.3	302.7	0.0	0.1	0.0	12.8	5.2	6.0	1109.8	4.9	1034.8	62.0	1123.8	1201.7	5.2	98.9	1260.7	1168.7	33.6	641.5	6.0	7.7	1682.7	1836.9	0.4	0.5	0.4	0.5	0.5	0.4	0.8	0.5	0.6	0.6	0.5	0.6	4.9	0.0	9.3	0.0	23.4	4.6	1.2	0.4	0.0	0.0	3.5	5.2	1.8	4.3	1.6	3.7	0.0	0.3	143.9	0.9	0.0	0.6	0.1	1.0	0.5	3.4	2.4	10.1	0.2	0.5	0.2	3.1	7.7	0.7	5.1	0.0	4.6	1.5	0.3	0.0	0.2	0.3	0.0	7.8	7.3	0.0	0.0	8.1	3.6	0.0	8.7	0.0	272.9	0.5	0.1	4.7	0.0	0.4	15.7	1.0	0.0	1.4	1.8	0.0	0.0	1.5	2.4	4.5	2.0	0.5	3.1	0.4	255.5	2.9	1.3	1.1
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.7	1.5	0.6	14.6	0.7	9.2	1.7	0.7	1.2	1.6	0.7	5.0	2.7	1.3	0.8	2.8	1.8	2.3	1.7	0.7	0.8	2.7	3.0	6.2	32.2	1.0	0.8	0.9	1.2	0.2	1.8	1.8	0.9	2.5	2.3	16.1	2.8	0.5	0.8	1.9	30.1	0.9	0.8	56.9	3.1	1.5	0.9	13.1	3.2	0.2	29.3	2.9	2.1	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.8	1.0	0.8	0.9	0.8	0.9	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.1;lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.7"	"Group enriched"	"Detected in many"	14	"B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019114	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	0.7	8.8	0.2	5.3	0.2	2.9	1.0	1.0	0.4	1.1	0.7	10.2	1.7	1.0	4.0	0.7	2.6	1.6	0.4	0.3	0.1	1.1	0.7	5.4	12.9	0.4	0.1	0.5	0.8	1.1	0.6	2.6	0.3	0.7	15.1	0.1	0.8	0.2	0.2	2.1	5.5	0.6	0.1	6.7	2.1	1.5	0.3	2.3	0.5	0.2	13.1	1.6	0.7	0.5	1.5	1.6	0.0	4.0	0.8	0.2	0.3	1.0	5.5	1.6	2.0	0.0	0.1	21.9	0.5	0.0	2.6	0.1	14.7	1.8	1.5	26.9	13.6	1.9	0.4	0.0	1.3	0.0	1.8	0.3	0.0	1.3	1.0	0.1	0.0	5.1	0.0	0.0	0.3	0.5	0.3	0.0	1.6	0.0	2.9	0.0	3.3	0.0	0.1	0.2	0.9	0.0	0.1	0.2	9.2	0.2	2.4	28.5	0.1	1.3	2.1	0.0	4.2	0.0	0.0	18.5	1.2	0.0	4.0	0.1	0.3	0.0	5.9	1.1	2.1	10.3	5.0	8.9	7.1	3.7	0.6	4.5	0.2	0.4	0.2	29.7	0.2	2.6	0.2	0.2	1.0	0.4	0.3	0.1	0.4	0.1	0.3	0.1	0.3	0.5	0.4	0.0	0.6	0.0	26.3	4.5	0.4	0.1	1.2	0.0	1.1	1.8	0.5	0.0	1.3	1.8	0.0	0.1	43.6	31.4	0.0	0.1	53.1	12.3	6.0	0.4	2.4	1.3	0.9	1.4	0.1	1.5	1.5	24.5	0.0	0.1	0.7	0.0	0.7	0.0	0.5	4.5	0.0	1.3	100.8	19.6	0.0	14.4	8.8	2.8	32.3	0.0	1.0	0.0	1.4	0.4	4.7	0.0	13.8	0.6	0.0	2.3	1.5	0.0	0.0	0.7	0.3	1.6	4.3	0.0	3.3	0.3	21.8	1.6	5.4	0.1
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78963727	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 256.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 121.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036757, HPA065766"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	0.8	0.5	0.4	14.6	0.5	8.2	0.9	1.4	1.1	1.0	0.0	2.7	3.1	0.8	0.3	1.1	0.4	3.2	0.4	0.4	0.1	0.4	1.6	2.4	27.4	0.2	0.0	0.4	1.5	0.0	0.1	0.3	0.2	1.3	3.6	0.6	1.2	0.2	0.2	0.6	6.4	0.7	0.0	16.6	3.9	0.3	0.2	10.3	0.6	0.1	25.8	5.4	0.4	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	121.8	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	9.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.1	0.0	26.5	0.1	1.4	0.2	0.3	0.1	256.1	0.2	158.1	12.6	0.9	11.4	73.1	28.0	25.5	4.0	74.1	25.7	19.5	27.9	18.1	10.9	2.8	41.7	13.2	0.4	0.5	1.4	1.1	0.4	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.7	0.0	1.7	0.0	79.3	1.8	0.0	0.0	0.0	0.0	0.3	0.3	1.2	0.0	0.6	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.5	0.1	29.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.6	38.5	0.0	0.0	3.6	8.8	0.0	32.5	0.0	9.2	0.0	0.0	0.0	0.0	0.0	32.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.0	0.0	55.1	0.0	0.0	0.3
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;lymphoid tissue: 45.7;retina: 29.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.4;Excitatory neurons: 54.1;Muller glia cells: 86.9;Plasma cells: 43.0;T-cells: 84.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 10.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 10.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 54.5;JURKAT: 70.2;MOLT-4: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.1	0.8	6.7	10.5	16.8	8.5	1.7	23.7	13.2	0.8	0.0	1.4	2.4	1.4	0.4	5.9	4.4	2.5	1.2	11.6	3.3	5.5	1.1	4.1	21.4	15.3	2.5	0.4	1.8	0.5	0.5	0.9	17.9	0.7	2.1	29.7	1.7	0.7	0.4	6.9	3.6	0.6	0.0	8.9	4.5	2.0	8.8	45.7	0.6	0.7	16.4	3.4	2.0	9.2	0.0	0.4	1.0	0.3	0.0	0.0	0.1	4.1	1.2	2.0	1.7	4.5	0.0	11.6	0.9	0.1	0.2	0.2	2.4	0.0	1.9	54.5	2.2	0.9	0.5	0.0	0.6	0.5	0.8	0.0	0.1	1.1	0.0	0.0	0.0	70.2	0.5	3.6	0.0	1.7	52.3	0.1	0.7	0.0	0.0	14.4	0.3	0.0	2.0	0.1	4.7	1.7	2.6	0.1	0.2	1.5	1.2	0.0	0.2	0.4	1.6	5.6	0.8	8.7	4.6	13.6	0.2	0.1	0.6	0.0	0.0	0.9	5.2	0.0	3.7	1.1	5.7	5.2	0.0	0.6	5.2	5.3	0.2	2.4	0.0	0.0	10.3	1.4	6.7	16.8	23.7	13.2	11.6	3.3	15.3	2.5	17.9	0.0	8.8	9.2	0.9	6.4	10.7	6.5	26.5	2.4	0.4	6.8	4.6	9.6	3.4	2.0	4.5	5.7	2.7	33.1	10.4	0.3	71.4	0.1	3.9	18.4	1.5	7.6	1.6	0.8	0.0	0.0	54.1	10.0	0.2	1.2	1.1	6.6	3.8	0.4	1.1	0.5	0.7	6.7	16.5	1.3	0.0	0.8	6.1	0.7	0.0	3.0	7.2	9.4	3.0	86.9	34.0	2.5	3.9	34.1	0.0	0.0	43.0	0.7	0.3	7.8	0.4	21.3	0.0	1.9	1.3	1.2	3.8	4.0	8.2	0.0	84.7	0.3	0.9	0.5
SEPTIN1	"DIFF6, PNUTL3, SEPT1"	ENSG00000180096	"Septin 1"	Q8WYJ6	16	30378133-30395991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 16.7;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.7;Cytotrophoblasts: 11.4;dendritic cells: 25.9;Fibroblasts: 4.9;Hofbauer cells: 9.2;Plasma cells: 10.2;Syncytiotrophoblasts: 4.9;T-cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;JURKAT: 48.5;MOLT-4: 66.3;REH: 39.0;U-266/70: 21.6;U-266/84: 33.4;U-698: 23.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.6	0.9	1.0	3.6	1.1	0.7	1.1	1.2	1.9	1.9	1.0	3.4	4.1	1.4	0.7	2.0	2.0	0.3	0.8	1.0	1.1	1.4	1.9	2.6	15.3	1.0	1.0	1.6	0.8	0.5	0.7	0.3	1.1	1.7	0.0	0.1	3.2	0.8	0.2	1.3	16.7	0.7	1.0	35.9	4.4	0.2	1.4	16.0	1.9	0.6	6.6	2.0	1.6	1.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	38.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.3	3.0	0.0	0.0	0.3	0.0	5.1	1.2	0.2	0.1	0.1	0.0	0.7	0.0	48.5	0.3	16.7	0.0	0.0	66.3	1.4	0.0	0.0	0.7	39.0	0.0	2.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	21.6	33.4	23.2	0.6	7.0	0.0	118.4	2.5	102.2	319.3	2.3	245.1	170.1	286.7	292.4	9.6	179.4	264.6	268.7	8.5	230.4	1.6	270.6	329.6	272.6	1.0	1.1	1.2	1.9	1.0	1.1	1.0	1.0	1.1	1.0	1.4	1.0	1.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	11.4	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.9	6.1	0.0	0.0	0.0
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TRAC		ENSG00000277734	"T cell receptor alpha constant"		14	22547506-22552156	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	7	"lymphoid tissue: 787.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 166.3;Rod photoreceptor cells: 75.9;T-cells: 428.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2"	"Lineage enriched"	"Detected in all"	41	"T-cells: 4379.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 127.0;JURKAT: 294.7;NB-4: 83.1;U-266/84: 126.2;U-698: 62.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"prognostic favorable (3.21e-4)"	"prognostic favorable (4.87e-6)"	"unprognostic (9.92e-3)"	"prognostic favorable (4.15e-6)"	"unprognostic (3.71e-2)"	"prognostic favorable (5.25e-5)"	"unprognostic (2.83e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.51e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (2.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.75e-2)"	17.5	7.7	5.4	157.5	14.8	29.5	16.9	6.9	3.9	12.0	2.4	33.6	46.6	9.3	39.3	17.2	10.0	42.2	45.3	2.0	2.0	10.5	16.5	47.0	394.3	3.4	8.2	7.3	3.3	1.9	11.4	2.3	4.0	15.3	43.4	112.7	25.8	5.5	3.3	19.5	78.3	10.4	2.5	134.1	54.9	7.2	2.2	787.9	12.2	2.7	287.6	58.4	9.7	2.3	0.3	0.0	11.6	0.0	0.0	0.0	0.2	0.1	0.4	0.3	0.4	1.8	0.0	11.4	1.5	0.0	0.2	0.0	0.2	0.1	1.1	127.0	0.0	0.2	0.0	0.0	0.0	16.4	0.8	0.0	0.0	4.3	0.2	0.0	3.1	294.7	0.4	0.1	1.2	0.0	45.7	83.1	3.1	0.1	0.6	22.9	2.8	0.2	0.7	0.0	0.0	0.2	0.0	0.0	1.1	1.7	0.0	1.6	8.3	3.4	0.7	0.3	1.0	2.7	126.2	62.1	1.0	0.5	0.1	24.5	10.2	9.8	520.5	6.7	2123.1	105.6	2939.7	2508.6	7.9	94.6	2671.8	2388.0	57.7	89.7	11.0	11.8	4379.2	2965.8	5.4	14.8	6.9	3.9	2.0	2.0	3.4	8.2	4.0	2.5	2.2	2.3	9.0	3.2	25.6	0.0	46.3	0.0	1.0	0.0	5.7	9.0	4.9	8.5	35.7	0.0	6.2	0.0	12.5	0.2	166.3	0.9	17.6	0.7	46.2	0.9	0.6	3.3	0.0	16.4	0.0	0.0	0.2	15.9	4.1	0.5	10.1	0.0	9.3	1.4	1.3	0.0	0.0	0.9	0.0	8.1	0.0	4.8	1.8	12.2	0.0	0.0	20.2	11.8	44.3	0.0	0.0	0.1	1.2	5.3	25.4	0.2	0.5	4.6	0.0	75.9	0.0	2.6	4.7	2.2	0.8	5.4	0.0	0.3	428.0	0.0	0.7	0.2
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 130.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 133.8;dendritic cells: 124.7;NK-cells: 407.8;T-cells: 162.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 115.2;JURKAT: 64.2;Karpas-707: 46.2;MOLT-4: 60.9;NB-4: 68.7;THP-1: 64.1;U-266/70: 68.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040796: AB_10794861"	"prognostic favorable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"	3.6	2.3	1.9	51.6	2.0	31.8	4.1	1.8	4.2	3.5	1.4	8.2	7.4	2.8	2.7	3.4	2.0	10.5	1.7	2.0	2.0	4.2	5.7	10.8	99.7	3.0	2.6	2.1	0.9	0.7	0.8	2.0	3.0	3.4	10.4	0.3	5.6	2.8	1.1	2.4	30.6	3.8	2.3	60.1	13.4	3.8	3.0	130.5	3.0	1.9	90.5	11.7	2.2	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	115.2	0.0	11.0	0.0	0.0	0.2	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	64.2	0.1	46.2	0.0	0.0	60.9	68.7	0.2	0.0	0.0	7.1	0.0	20.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	64.1	0.0	0.0	0.1	0.0	0.1	68.1	25.6	4.7	0.0	31.9	0.1	456.2	155.3	169.6	296.7	171.1	317.7	300.5	410.4	343.1	164.1	287.8	459.3	365.0	41.2	345.1	209.8	121.6	587.1	414.3	1.9	2.0	1.8	4.2	2.0	2.0	3.0	2.6	3.0	2.3	3.0	3.7	1.6	3.2	9.6	0.3	133.8	2.3	4.8	1.2	1.2	1.7	1.5	1.9	0.7	2.8	0.2	0.0	0.0	0.5	124.7	0.4	11.7	0.1	11.3	14.8	0.9	2.1	0.0	22.9	0.4	0.2	0.3	1.4	2.0	48.0	58.2	0.0	6.1	3.8	22.3	0.0	0.4	0.4	0.0	24.7	12.6	9.0	0.3	40.8	10.6	39.4	69.8	0.2	407.8	0.0	0.7	0.0	0.1	0.0	64.1	2.4	0.4	12.8	0.9	0.4	0.0	0.7	1.2	8.0	0.6	2.6	2.3	0.4	162.8	0.0	0.6	1.8
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"		7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 115.8;lymphoid tissue: 190.2"	"Group enriched"	"Detected in many"	4	"B-cells: 164.7;dendritic cells: 358.8;NK-cells: 264.7;T-cells: 498.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.0"	"Cell line enriched"	"Detected in some"	45	"MOLT-4: 277.9"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"prognostic favorable (8.04e-5)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.19e-3)"	"prognostic favorable (3.42e-8)"	"unprognostic (5.53e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.53e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.09e-3)"	18.9	3.1	0.4	3.9	0.3	1.5	8.6	0.1	1.2	11.9	0.1	21.2	1.7	8.7	0.0	14.6	15.7	2.2	4.9	0.3	0.0	9.6	12.7	32.3	8.6	0.2	0.3	18.3	3.5	0.1	4.0	0.0	0.2	14.2	2.7	0.0	7.9	0.1	3.3	6.5	115.8	0.5	0.1	190.2	16.9	8.7	0.3	109.2	16.4	1.2	10.9	14.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	3.5	0.0	0.0	0.0	0.0	277.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	14.4	0.0	35.0	8.1	47.6	47.3	0.3	7.7	46.6	40.3	2.0	10.5	0.1	0.0	76.0	42.4	0.4	0.3	0.1	1.2	0.3	0.0	0.2	0.3	0.2	0.1	0.3	0.1	8.3	9.6	52.4	0.0	164.7	0.0	0.3	0.0	1.8	0.1	6.2	9.7	4.8	5.7	3.7	1.8	0.0	0.4	358.8	1.4	0.0	2.9	1.0	1.1	0.8	4.0	0.0	16.6	0.0	1.3	0.1	10.8	8.6	0.9	20.2	0.0	15.0	1.6	0.4	0.0	0.0	0.8	0.0	9.0	0.0	4.2	63.6	18.9	0.0	0.0	19.0	15.6	264.7	0.0	0.0	20.1	0.1	70.3	30.6	0.4	0.1	2.2	2.9	0.4	65.7	4.2	12.4	0.1	0.8	1.3	0.0	0.3	498.0	1.4	0.9	0.2
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0